Cognoptix President And CEO Paul Hartung Tells Neurotech Investors: “Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care.”

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix President and CEO Paul Hartung told a group of investors this week: “Our vision is to change the course of Alzheimer’s disease by enabling early diagnosis at the point of care.”

Help employers find you! Check out all the jobs and post your resume.